Bullosis Diabeticorum.
Chouk C, Litaiem N.
2024 Jan 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Correlates of Medication Adherence in the TODAY Cohort of Youth With Type 2 Diabetes.
Katz LL, Anderson BJ, McKay SV, Izquierdo R, Casey TL, Higgins LA, Wauters A, Hirst K, Nadeau KJ; TODAY Study Group.
Diabetes Care. 2016 Nov;39(11):1956-1962. doi: 10.2337/dc15-2296. Epub 2016 Jun 28.
Linagliptin-associated blistering and ulceration.
Psomadakis C, Shahzad N, Katz J.
BMJ Case Rep. 2017 May 31;2017:bcr2017219998. doi: 10.1136/bcr-2017-219998.
Linagliptin-Associated Alopecia and Bullous Pemphigoid.
Someili A, Azzam K, Hilal MA.
Eur J Case Rep Intern Med. 2019 Sep 10;6(9):001207. doi: 10.12890/2019_001207. eCollection 2019.
Teneligliptin, a DPP-4 Inhibitor, Decreases Plasma Levels of Inflammatory Chemokines During a Standard Meal Test in Patients With Type 2 Diabetes.
Aso Y, Kase M, Sagara M, Sakurai S, Iijima T, Tomaru T, Jojima T, Usui I.
Am J Med Sci. 2020 Sep;360(3):261-267. doi: 10.1016/j.amjms.2020.05.005. Epub 2020 May 11.
A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B, Pal J, Das S, Charaborty SK, SircarMedical NR, Kolkata, RGKar, NorthBengal, Siliguri.
J Assoc Physicians India. 2023 Jan;71(1):1.
Necrotizing fasciitis.
Pessa ME, Howard RJ.
Surg Gynecol Obstet. 1985 Oct;161(4):357-61.
Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin.
Chouchane K, Di Zenzo G, Pitocco D, Calabrese L, De Simone C.
J Transl Med. 2021 Dec 20;19(1):520. doi: 10.1186/s12967-021-03192-8.
Current concepts in the management of necrotizing fasciitis.
Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A.
Front Surg. 2014 Sep 29;1:36. doi: 10.3389/fsurg.2014.00036. eCollection 2014.
Herpes Zoster Following COVID-19 Vaccine Booster.
Shahrudin MS, Mohamed-Yassin MS, Nik Mohd Nasir NM.
Am J Case Rep. 2023 Jan 18;24:e938667. doi: 10.12659/AJCR.938667.
